Document Detail


Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.
MedLine Citation:
PMID:  20826623     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Blacks have lower average triglyceride and LDL cholesterol concentrations than do whites but higher rates of coronary heart disease. Apolipoprotein (apo) C-III in VLDL and LDL stimulates atherogenic processes in vascular cells. In blacks, the concentration of lipoproteins with apo C-III is unknown, and the response to dietary strategies that lower triglyceride and apo C-III has not been investigated
OBJECTIVE: We compared the concentration of and dietary effects on apo C-III-containing lipoproteins in blacks and whites.
DESIGN: In a randomized, 3-period feeding study [OmniHeart (Optimal Macronutrient Intake Trial to Prevent Heart Disease)], we measured lipoprotein concentrations in 89 blacks and 73 whites who consumed self-selected diets (baseline) and after 3 healthful diets emphasizing carbohydrate, unsaturated fat, or protein. Participants had prehypertension or hypertension, and 79% were overweight or obese.
RESULTS: While consuming self-selected diets, blacks had lower apo C-III in total plasma, VLDL, and LDL than did whites. Unsaturated fat and protein diets lowered plasma apo C-III (16% and 18%, respectively) and triglyceride (12% and 21%, respectively) in whites but not in blacks, reducing racial differences. Most important, blacks had a lower concentration of atherogenic LDL with apo C-III at baseline and after study diets (34-41% lower, P < 0.02). The molar ratio of apo E to apo B was higher in blacks than in whites in total plasma and LDL at baseline and after the study diets.
CONCLUSIONS: Blacks have lower concentrations of atherogenic lipoproteins that contain apo C-III than do whites when consuming diverse diets and an attenuated dietary response of triglyceride and apo C-III. Dietary efforts to lower triglyceride and apo C-III may be more effective in whites than in blacks. The OmniHeart Trial was registered at www.clinicaltrials.gov as NCT00051350.
Authors:
Jeremy D Furtado; Hannia Campos; Anne E Sumner; Lawrence J Appel; Vincent J Carey; Frank M Sacks
Related Documents :
2149913 - Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lip...
6615243 - Lecithin:cholesterol acyltransferase, lipids and lipoproteins in maternal and umbilical...
17126823 - Novel carbonyl and nitrile products from reactive chlorinating species attack of lysosp...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2010-09-08
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  92     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-21     Completed Date:  2010-10-27     Revised Date:  2012-05-07    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  714-22     Citation Subset:  AIM; IM    
Affiliation:
Harvard School of Public Health, Boston, MA, USA. jfurtado@hsph.harvard.edu
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00051350
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Continental Ancestry Group / statistics & numerical data*
Aged
Apolipoprotein C-III / blood*
Apolipoproteins / blood
Cholesterol, HDL / blood
Coronary Disease / epidemiology,  mortality
Diet*
European Continental Ancestry Group / statistics & numerical data*
Female
Heart Diseases / epidemiology
Humans
Hypertension / epidemiology
Lipoproteins / metabolism*
Lipoproteins, LDL / blood
Lipoproteins, VLDL / blood
Male
Middle Aged
Obesity / epidemiology
Triglycerides / blood
Grant Support
ID/Acronym/Agency:
DK63214/DK/NIDDK NIH HHS; HL67098/HL/NHLBI NIH HHS; HL68712/HL/NHLBI NIH HHS; P30 DK040561-15/DK/NIDDK NIH HHS; RR02635/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoprotein C-III; 0/Apolipoproteins; 0/Cholesterol, HDL; 0/Lipoproteins; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Triglycerides
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Online continuing education program.
Next Document:  Total antioxidant capacity of diet in relation to cognitive function and decline.